Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 103 entries
View as:

A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea

Phase: N/A Priority: Normal
NCT ID: NCT02817347 Org: User:
Start: 06/30/16 End: 04/13/17 Due: 04/13/18

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT03217409 Org: User:
Start: 08/10/17 End: 05/23/19 Due: 05/23/20

Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02620163 Org: User:
Start: 12/31/15 End: 12/31/16 Due: 12/31/17

Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT05162274 Org: User:
Start: 11/30/21 End: 01/14/22 Due: 01/14/23

Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg

Phase: N/A Priority: Normal
NCT ID: NCT04316065 Org: User:
Start: 04/11/20 End: 04/24/20 Due: 04/24/21

Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT03116516 Org: User:
Start: 04/21/17 End: 05/26/17 Due: 05/26/18

Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

Phase: N/A Priority: Normal
NCT ID: NCT01750437 Org: User:
Start: 01/31/13 End: 04/30/14 Due: 04/30/15

High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03494270 Org: User:
Start: 03/18/18 End: 09/26/19 Due: 09/26/20

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT03267329 Org: User:
Start: 09/11/17 End: 09/02/20 Due: 09/02/21

Bioequivalence Study of Letrozole 2.5 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01084499 Org: User:
Start: 01/31/09 End: 05/31/09 Due: 05/31/10

Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448

Phase: N/A Priority: Normal
NCT ID: NCT03556436 Org: User:
Start: 07/03/18 End: 12/30/18 Due: 12/30/19

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06041529 Org: User:
Start: 10/18/23 End: 10/28/25 Due: 10/28/26

High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03403556 Org: User:
Start: 03/27/18 End: 12/31/21 Due: 12/31/22

Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01525147 Org: User:
Start: 12/31/11 End: 11/30/13 Due: 11/30/14

Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03662620 Org: User:
Start: 10/05/18 End: 12/22/18 Due: 12/22/19

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05960708 Org: User:
Start: 08/23/23 End: 09/13/24 Due: 09/13/25

Safety and Efficacy of YHD1023 in Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01423370 Org: User:
Start: 11/30/11 End: 03/31/13 Due: 03/31/14

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

Phase: N/A Priority: Normal
NCT ID: NCT06046196 Org: User:
Start: 11/18/20 End: 03/09/23 Due: 03/09/24

Food Effect on Pharmacokinetics of YH4808 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01520012 Org: User:
Start: 02/29/12 End: 06/30/12 Due: 06/30/13

A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05012436 Org: User:
Start: 07/24/21 End: 05/10/22 Due: 05/10/23

AME Study of [14C]-YH4808 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01825707 Org: User:
Start: 01/31/13 End: 03/31/13 Due: 03/31/14

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT05523947 Org: User:
Start: 08/26/22 End: 12/01/26 Due: 12/01/27

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06975410 Org: User:
Start: 06/12/25 End: 12/31/29 Due: 12/31/30

Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients

Phase: N/A Priority: Normal
NCT ID: NCT03823274 Org: User:
Start: 04/01/19 End: 01/03/22 Due: 01/03/23

A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT05730621 Org: User:
Start: 01/11/23 End: 02/28/24 Due: 02/28/25